Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8524800rdf:typepubmed:Citationlld:pubmed
pubmed-article:8524800lifeskim:mentionsumls-concept:C0205145lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C0080113lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1155873lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1145667lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C2825311lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C2349209lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:8524800lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:8524800pubmed:issue25lld:pubmed
pubmed-article:8524800pubmed:dateCreated1996-1-24lld:pubmed
pubmed-article:8524800pubmed:abstractTextAn intact T/E1A-binding domain (the pocket) is necessary, but not sufficient, for the retinoblastoma protein (RB) to bind to DNA-protein complexes containing E2F and for RB to induce a G1/S block. Indirect evidence suggests that the binding of RB to E2F may, in addition to inhibiting E2F transactivation function, generate a complex capable of functioning as a transrepressor. Here we show that a chimera in which the E2F1 transactivation domain was replaced with the RB pocket could, in a DNA-binding and pocket-dependent manner, mimic the ability of RB to repress transcription and induce a cell cycle arrest. In contrast, a transdominant negative E2F1 mutant that is capable of blocking E2F-dependent transactivation did not. Fusion of the RB pocket to a heterologous DNA-binding domain unrelated to E2F likewise generated a transrepressor protein when scored against a suitable reporter. These results suggest that growth suppression by RB is due, at least in part, to transrepression mediated by the pocket domain bound to certain promoters via E2F.lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:languageenglld:pubmed
pubmed-article:8524800pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:citationSubsetIMlld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8524800pubmed:statusMEDLINElld:pubmed
pubmed-article:8524800pubmed:monthDeclld:pubmed
pubmed-article:8524800pubmed:issn0027-8424lld:pubmed
pubmed-article:8524800pubmed:authorpubmed-author:KaelinW GWGJrlld:pubmed
pubmed-article:8524800pubmed:authorpubmed-author:SellersW RWRlld:pubmed
pubmed-article:8524800pubmed:authorpubmed-author:RodgersJ WJWlld:pubmed
pubmed-article:8524800pubmed:issnTypePrintlld:pubmed
pubmed-article:8524800pubmed:day5lld:pubmed
pubmed-article:8524800pubmed:volume92lld:pubmed
pubmed-article:8524800pubmed:ownerNLMlld:pubmed
pubmed-article:8524800pubmed:authorsCompleteYlld:pubmed
pubmed-article:8524800pubmed:pagination11544-8lld:pubmed
pubmed-article:8524800pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:meshHeadingpubmed-meshheading:8524800-...lld:pubmed
pubmed-article:8524800pubmed:year1995lld:pubmed
pubmed-article:8524800pubmed:articleTitleA potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.lld:pubmed
pubmed-article:8524800pubmed:affiliationDana-Farber Cancer Institute, Boston, MA, USA.lld:pubmed
More...